Moore Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Buy |
+250,000
| New | +$2.91M | 0.04% | 242 |
|
|
2022
Q4 | – | Sell |
-145,792
| Closed | -$1.04M | – | 531 |
|
|
2022
Q3 | $1.04M | Buy |
145,792
+121,102
| +490% | +$862K | 0.02% | 387 |
|
|
2022
Q2 | $200K | Sell |
24,690
-28,679
| -54% | -$232K | 0.01% | 429 |
|
|
2022
Q1 | $741K | Sell |
53,369
-103,242
| -66% | -$1.43M | 0.02% | 425 |
|
|
2021
Q4 | $4.4M | Buy |
156,611
+54,289
| +53% | +$1.52M | 0.09% | 236 |
|
|
2021
Q3 | $3.48M | Buy |
102,322
+21,312
| +26% | +$724K | 0.05% | 318 |
|
|
2021
Q2 | $3.31M | Buy |
81,010
+54,401
| +204% | +$2.22M | 0.05% | 342 |
|
|
2021
Q1 | $1.07M | Sell |
26,609
-80,770
| -75% | -$3.25M | 0.01% | 483 |
|
|
2020
Q4 | $6.35M | Buy |
+107,379
| New | +$6.35M | 0.07% | 176 |
|